Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Brain Res Bull ; 147: 47-57, 2019 04.
Artículo en Inglés | MEDLINE | ID: mdl-30771409

RESUMEN

Hearing loss and cognitive decline are commonly associated with aging and morbidity. Present clinical interest lies in whether peripheral hearing loss promotes cognitive decline and if prophylaxis with selective adenosine receptor agonist CGS21680 effectively mitigates the adverse effects. In the current study, male Sprague Dawley rats weighing 200-250 g m were randomly allocated into three groups: Group 1) rats exposed to 100 dB SPL white noise, 2 h a day for 15 consecutive days, 2) rats supplemented with an adenosine receptor agonist, CGS21680 at 100 µg/kg/day prior to noise exposure and 3) unexposed control rats. Baseline hearing and cognition assessed by auditory brainstem response (ABR) and water maze respectively was undertaken for all the groups. Phalloidin stain and synaptic ribbons count in cochlea, and, Ki67, DCX and NeuN in hippocampus were observed by immunohistochemistry. It was inferred that noise exposed rats showed elevated thresholds of ABR and poorer performances in spatial working memory when compared with controls. On the contrary, CGS21680 administered group exhibited improved ABR and cognitive functions with shorter mean latency and path-length to reach the platform, significant reduction in the noise induced loss of synaptic ribbons count and increased number of Ki67 and doublecortin (DCX) positive cells compared to their noise exposed counterparts. Pharmacologic intervention with selective A2A receptor agonist CGS21680 provided adequate protection from noise by effectively maintaining hearing threshold levels, cell viability in cochlea and hippocampus & functional/intact reference memory.


Asunto(s)
Adenosina/análogos & derivados , Pérdida Auditiva Provocada por Ruido/tratamiento farmacológico , Neurogénesis/efectos de los fármacos , Fenetilaminas/farmacología , Estimulación Acústica , Adenosina/metabolismo , Adenosina/farmacología , Agonistas del Receptor de Adenosina A2/farmacología , Animales , Cóclea , Disfunción Cognitiva/tratamiento farmacológico , Disfunción Cognitiva/fisiopatología , Proteína Doblecortina , Potenciales Evocados Auditivos del Tronco Encefálico/efectos de los fármacos , Pérdida Auditiva/tratamiento farmacológico , Pérdida Auditiva/fisiopatología , Pérdida Auditiva Provocada por Ruido/fisiopatología , Hipocampo , Masculino , Memoria , Neurogénesis/fisiología , Ruido/efectos adversos , Fenetilaminas/metabolismo , Ratas , Ratas Sprague-Dawley , Receptor de Adenosina A2A/metabolismo
2.
Noise Health ; 13(55): 452-8, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-22122962

RESUMEN

The study explores the effect of occupational noise on oxidative stress status and prophylactic effect of Vitamin E and carbogen (5% CO 2 +95%O 2 ) breathing in alleviating the oxidative damage and conserving the hearing in human volunteers exposed to intense occupational noise. Plasma total antioxidant status, blood glutathione (GSH), malondialdehyde (MDA), antioxidant enzyme activities of GSH peroxidase (EC 1.11.1.9, GPx), superoxide dismutase (EC 1.15.1.1; SOD) in erythrocytes, nitric oxide and nitric oxide synthase in plasma were assessed before and after 6 days of administration of Vitamin E and Carbogen. Results of the study indicate that the exposure to noise for 6 days increased blood concentration of MDA, decreased concentrations of reduced GSH, antioxidant enzyme activity of SOD and plasma total antioxidant status in control (noise) group. Vitamin E- supplemented group showed decline in oxidative stress reflected by significant decrease in blood concentration of MDA and increase in antioxidant enzyme activity of erythrocyte SOD. Results of audiometric studies revealed that breathing of carbogen prevented the development of temporary threshold shift; thereby reducing the risk of noise induced hearing loss.


Asunto(s)
Dióxido de Carbono/farmacología , Pérdida Auditiva Provocada por Ruido/prevención & control , Ruido en el Ambiente de Trabajo/efectos adversos , Estrés Oxidativo/efectos de los fármacos , Oxígeno/farmacología , Vitamina E/farmacología , Administración por Inhalación , Adulto , Análisis de Varianza , Audiometría , Análisis Químico de la Sangre , Dióxido de Carbono/administración & dosificación , Suplementos Dietéticos , Glutatión/sangre , Glutatión/fisiología , Pérdida Auditiva Provocada por Ruido/sangre , Humanos , Masculino , Malondialdehído/sangre , Personal Militar , Óxido Nítrico/sangre , Óxido Nítrico/fisiología , Ruido en el Ambiente de Trabajo/prevención & control , Estrés Oxidativo/fisiología , Oxígeno/administración & dosificación , Superóxido Dismutasa/sangre , Superóxido Dismutasa/fisiología , Vitamina E/administración & dosificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA